ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
+3.05%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
AUM
$225M
AUM Growth
+$225M
Cap. Flow
-$7.59M
Cap. Flow %
-3.38%
Top 10 Hldgs %
93.85%
Holding
15
New
Increased
6
Reduced
5
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARWR icon
1
Arrowhead Research
ARWR
$3.55B
$44.8M 16.81%
1,103,515
-115,000
-9% -$4.66M
BPMC
2
DELISTED
Blueprint Medicines
BPMC
$25.5M 9.57%
581,768
+57,500
+11% +$2.52M
ARVN icon
3
Arvinas
ARVN
$580M
$23.1M 8.66%
673,941
+2,196
+0.3% +$75.1K
MRUS icon
4
Merus
MRUS
$5.01B
$22.2M 8.32%
1,432,109
-75,000
-5% -$1.16M
RGNX icon
5
Regenxbio
RGNX
$461M
$20.4M 7.65%
897,684
-70,000
-7% -$1.59M
SLN
6
Silence Therapeutics
SLN
$225M
$19.6M 7.36%
1,284,133
+21,008
+2% +$320K
KYMR icon
7
Kymera Therapeutics
KYMR
$2.91B
$15.7M 5.9%
629,411
+299,165
+91% +$7.47M
AMYT
8
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$15.3M 5.76%
2,098,993
+100,000
+5% +$730K
QURE icon
9
uniQure
QURE
$933M
$14.2M 5.32%
624,854
-216,617
-26% -$4.91M
GMAB icon
10
Genmab
GMAB
$15.9B
$10.3M 3.87%
242,848
-2,000
-0.8% -$84.8K
ARGX icon
11
argenx
ARGX
$43.2B
$9.09M 3.42%
24,000
PVLA
12
Palvella Therapeutics, Inc. Common Stock
PVLA
$583M
$4.73M 1.78%
4,552,876
+516,596
+13% +$537K
FDMT icon
13
4D Molecular Therapeutics
FDMT
$287M
-3,573
Closed -$29K
SPRO icon
14
Spero Therapeutics
SPRO
$115M
-3,403,210
Closed -$6.81M
XBI icon
15
SPDR S&P Biotech ETF
XBI
$5.25B
0